All productsSemax + Selank
Size
- 20 mg — $80.00 CAD — Available
Research focus
A blend whose ingredients have separate preclinical studies in rat brain-ischaemia and stress models.
In simple words
Semax + Selank is a blend of two peptides studied separately in nervous-system research. The selected studies use rat brain-ischaemia and stress models; they do not establish cognitive or mood benefits of the blend in people.
Ingredient studies are shown separately. They do not demonstrate the effects, safety or synergy of the combined vial; exact sequences and unlisted proportions are not assumed.
Research references
Reviewed 2026-10-26
Preclinical — rats
Male Wistar rats; protein analyses used 5–7 animals per group.
The ACTH-derived analogue altered selected brain proteins associated with inflammation, cell death and recovery after experimentally induced ischaemia.
A rat stroke model does not establish cognitive enhancement or stroke treatment in humans, and did not test the Selank/Semax blend.
PMID 34201112. Open full text checked through Europe PMC on 2026-10-26. Selected evidence, not a systematic review.
Preclinical — rats
Rats under chronic mild stress and comparison conditions; group sizes not specified in the reviewed abstract.
Researchers measured elevated-plus-maze behaviour after Selank, diazepam or both. Effects varied with the stress conditions.
Behaviour in rats does not establish human anxiety treatment, safety, or the effects of a Selank/Semax blend.
PMID 28280289. Indexed abstract checked through Europe PMC on 2026-10-26. Selected evidence, not a systematic review.
Resources
Identity search; no unambiguous compound record assigned to this listing. Check forms and synonyms carefully.
PubChemMechanism and target search. Automated access returned 403; DrugBank was not used to substantiate claims or approval status.
DrugBankProtein/precursor search, not a record of the supplied vial. Synthetic compounds and lab supplies may have no matching protein entry.
UniProtBioactivity search. Assay results depend on the tested compound, target and experimental conditions.
ChEMBLExplore indexed literature. Search results are not supporting citations; selected verified publications appear above.
PubMedExplore registrations. A match or completed study does not establish efficacy, approval or relevance to this vial.
ClinicalTrials.govEvidence on studied compounds does not establish the identity, purity, safety, or regulatory approval of the catalogue vial. No Canadian regulatory status is assessed here.
Research questions about Semax + Selank
What is Semax + Selank?
Semax + Selank is a blend of two peptides studied separately in nervous-system research. The selected studies use rat brain-ischaemia and stress models; they do not establish cognitive or mood benefits of the blend in people.
What types of research are cited for Semax + Selank?
The Semax + Selank profile contains the following selected evidence on individual ingredients. This is not a systematic review or a complete inventory of research.
Semax in a rat cerebral-ischaemia model (2021): Preclinical — rats
Publication: Semax in a rat cerebral-ischaemia modelSelank in a rat stress model (2017): Preclinical — rats
Publication: Selank in a rat stress modelWho or what was studied in the selected Semax + Selank references?
Semax in a rat cerebral-ischaemia model (2021): Male Wistar rats; protein analyses used 5–7 animals per group.
Publication: Semax in a rat cerebral-ischaemia modelSelank in a rat stress model (2017): Rats under chronic mild stress and comparison conditions; group sizes not specified in the reviewed abstract.
Publication: Selank in a rat stress modelDo the selected studies test the exact Semax + Selank blend?
Ingredient studies are shown separately. They do not demonstrate the effects, safety or synergy of the combined vial; exact sequences and unlisted proportions are not assumed.
What do the selected Semax + Selank studies not establish?
Semax in a rat cerebral-ischaemia model (2021): A rat stroke model does not establish cognitive enhancement or stroke treatment in humans, and did not test the Selank/Semax blend.
Publication: Semax in a rat cerebral-ischaemia modelSelank in a rat stress model (2017): Behaviour in rats does not establish human anxiety treatment, safety, or the effects of a Selank/Semax blend.
Publication: Selank in a rat stress modelThese studies do not establish the identity, purity, safety or effects of the MXC Semax + Selank vial. Findings in one formulation, population or experimental model should not be assumed to apply to another.